dacarbazine has been researched along with Cancer of Parathyroid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O | 1 |
| Barlier, A; Barrie, M; Brue, T; Castinetti, F; Conte-Devolx, B; Dufour, H; Morange, I; Philippon, M; Taieb, D | 1 |
| Calandra, DB; Chejfec, G; Foy, BK; Lawrence, AM; Paloyan, E | 1 |
3 other study(ies) available for dacarbazine and Cancer of Parathyroid
| Article | Year |
|---|---|
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperparathyroidism, Primary; Male; Mechlorethamine; Neoplasms, Second Primary; Parathyroid Neoplasms; Prednisone; Procarbazine; Vinblastine; Vincristine | 2010 |
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
Topics: Adult; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Dopamine Agonists; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypophysectomy; Hypopituitarism; Male; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Neoplasm Recurrence, Local; Ophthalmoplegia; Pancreatic Neoplasms; Parathyroid Neoplasms; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins; Radiotherapy, Adjuvant; Remission Induction; Spinal Neoplasms; Temozolomide | 2012 |
Parathyroid carcinoma: biochemical and pathologic response to DTIC.
Topics: Adult; Calcium; Carcinoma; Dacarbazine; Female; Humans; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms | 1984 |